A Study to Evaluate Absolute Bioavailability, Absorption, Metabolism, and Excretion of Genz-112638 in Healthy Male Participants

NCT06143904 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Gaucher's Disease Type I

Interventions

DRUG: Genz-112638
DRUG: Genz-112638
DRUG: [14C]-Genz-112638

Sponsor

Sanofi